BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3925088)

  • 1. Production of mitomycin C and porfiromycin by Streptomyces species.
    Mandwal AK; Subramanian PM; Bhatia MC; Kapil RS; Popli SP; Vora VC
    J Nat Prod; 1985; 48(2):334. PubMed ID: 3925088
    [No Abstract]   [Full Text] [Related]  

  • 2. New mitomycin analogs produced by directed biosynthesis.
    Claridge CA; Bush JA; Doyle TW; Nettleton DE; Moseley JE; Kimball D; Kammer MF; Veitch J
    J Antibiot (Tokyo); 1986 Mar; 39(3):437-46. PubMed ID: 3700245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium arsenite on the biosynthesis of mitomycins by Streptomyces caespitosus and mode of action of mitomycin C on Bacillus subtilis NRRL B-543.
    Abou-Zeid AA; Yousef AA
    Folia Microbiol (Praha); 1976; 21(1):36-42. PubMed ID: 814067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.
    IYER VN; SZYBALSKI W
    Science; 1964 Jul; 145(3627):55-8. PubMed ID: 14162693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-glucosamine and L-citrulline, precursors in mitomycin biosynthesis by Streptomyces verticillatus.
    Hornemann Y; Kehrer JP; Nunez CS; Ranieri RL
    J Am Chem Soc; 1974 Jan; 96(1):320-2. PubMed ID: 4810575
    [No Abstract]   [Full Text] [Related]  

  • 6. Utilization of the intact carbamoyl group of L-(NH2CO-13C,15N) citrulline in mitomycin biosynthesis by Streptomyces verticillatus.
    Hornemann U; Eggert JH
    J Antibiot (Tokyo); 1975 Oct; 28(10):841-3. PubMed ID: 1184475
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosynthesis of mitomycins by Streptomyces caespitosus.
    Abou-Zeid AZ; Yousef AS
    Acta Microbiol Pol B; 1974; 6(4):171-5. PubMed ID: 4476176
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors affecting the biosynthesis of mitomycins by Streptomyces caespitosus.
    Abou-Zeid AZ; Yousef AS
    Acta Microbiol Pol B; 1972; 4(3):119-26. PubMed ID: 4645860
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA; Herman TS; Teicher BA
    Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyquinone O-methylation in mitomycin biosynthesis.
    Grüschow S; Chang LC; Mao Y; Sherman DH
    J Am Chem Soc; 2007 May; 129(20):6470-6. PubMed ID: 17461583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):456-60. PubMed ID: 8552660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
    Na Y; Wang S; Kohn H
    J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of profiromycin vs mitomycin-C utilizing acute intermittent schedules.
    Baker LH; Izbicki RM; Vaitkevicius VK
    Med Pediatr Oncol; 1976; 2(2):207-13. PubMed ID: 958162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the biosynthesis of mitomycins by Streptomyces caespitosus.
    Abou-Zeid AA; Yousef AA
    Acta Microbiol Pol A; 1972; 4(3):119-26. PubMed ID: 4627036
    [No Abstract]   [Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PORFIROMYCIN.
    DUVALL LR
    Cancer Chemother Rep; 1963 Jul; 30():35-43. PubMed ID: 14051502
    [No Abstract]   [Full Text] [Related]  

  • 19. Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
    Musser SM; Pan SS; Callery PS
    J Chromatogr; 1989 Jul; 474(1):197-207. PubMed ID: 2504760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.